We are live on
!
Find out more
Bessemer Group Portfolio holdings
AUM
$63.6B
1-Year Est. Return
28.76%
This Fund
S&P 500
This Quarter
Est. Return
+6.36%
1 Year Est. Return
+28.76%
3 Year Est. Return
+103.2%
5 Year Est. Return
+139.19%
10 Year Est. Return
+508.5%
AUM
$29.7B
AUM Growth
+$3.64B
(+14%)
Cap. Flow
+$2.12B
Cap. Flow
% of AUM
7.14%
Top 10 Holdings %
Top 10 Hldgs %
19.86%
Holding
1,952
New
182
Increased
563
Reduced
543
Closed
315
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$294M |
| 2 |
JPMorgan Chase
JPM
|
+$248M |
| 3 |
VanEck Gold Miners ETF
GDX
|
+$193M |
| 4 |
Visa
V
|
+$122M |
| 5 |
Elanco Animal Health
ELAN
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$125M |
| 2 |
Markel Group
MKL
|
+$124M |
| 3 |
WP
Worldpay, Inc.
WP
|
+$121M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$120M |
| 5 |
OPLN
Openlane
OPLN
|
+$83.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17% |
| 2 | Financials | 15.46% |
| 3 | Healthcare | 14.98% |
| 4 | Consumer Discretionary | 12.82% |
| 5 | Industrials | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Incyte
INCY
$23.5B
| $48M | 0.16% |
564,490
+564,002
| +115,574% | +$45.3M |
|
152
Progressive
PGR
$124B
| $46.3M | 0.16% |
579,858
+65,076
| +13% | +$5.03M |
|
153
Brown-Forman Class B
BF.B
$12B
| $46.1M | 0.16% |
831,164
-11,729
| -1% | -$626K |
|
|
SCHW
154
Charles Schwab
SCHW
$177B
| $45.8M | 0.15% |
1,139,982
+1,015,649
| +817% | +$44.3M |
|
155
Intel
INTC
$466B
| $45.5M | 0.15% |
951,488
+122,824
| +15% | +$6.09M |
|
156
Clorox
CLX
$11.6B
| $42.8M | 0.14% |
279,522
-334,105
| -54% | -$51M |
|
157
Boeing
BA
$165B
| $41.6M | 0.14% |
114,276
-378
| -0.3% | -$138K |
|
|
WCN
158
Waste Connections
WCN
$42.8B
| $40.8M | 0.14% |
426,942
-129,338
| -23% | -$11.9M |
|
159
Motorola Solutions
MSI
$69.4B
| $40.5M | 0.14% |
243,041
-325,660
| -57% | -$49.1M |
|
160
State Street SPDR S&P Regional Banking ETF
KRE
$4.86B
| $40.1M | 0.14% |
+751,000
| New | +$40.1M |
|
161
Vanguard Extended Market ETF
VXF
$30.3B
| $39.3M | 0.13% |
331,795
-76,594
| -19% | -$8.95M |
|
162
Regeneron Pharmaceuticals
REGN
$68.8B
| $38.6M | 0.13% |
123,432
+122,811
| +19,776% | +$40.9M |
|
|
ABMD
163
DELISTED
Abiomed Inc
ABMD
| $38.6M | 0.13% |
148,135
+148,023
| +132,163% | +$39.3M |
|
|
ARI
164
Apollo Commercial Real Estate
ARI
$887M
| $38.4M | 0.13% |
2,085,361
-1,415,781
| -40% | -$26.4M |
|
|
XLNX
165
DELISTED
Xilinx Inc
XLNX
| $37.8M | 0.13% |
320,794
-862
| -0.3% | -$100K |
|
|
FLG
166
Flagstar Bank National Association
FLG
$5.77B
| $37.5M | 0.13% |
1,253,365
-1,018
| -0.1% | -$32.9K |
|
167
Abbott
ABT
$180B
| $37.3M | 0.13% |
443,584
-1,152
| -0.3% | -$90.7K |
|
168
Spire
SR
$4.92B
| $35.9M | 0.12% |
427,635
-144,767
| -25% | -$12.1M |
|
|
EQC
169
DELISTED
Equity Commonwealth
EQC
| $34.9M | 0.12% |
1,073,293
-368,047
| -26% | -$12M |
|
170
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27B
| $34.3M | 0.12% |
96,616
-6,880
| -7% | -$2.4M |
|
|
MFA
171
MFA Financial
MFA
$929M
| $34.2M | 0.12% |
1,189,310
-579,169
| -33% | -$16.9M |
|
172
Cheesecake Factory
CAKE
$4.21B
| $34M | 0.11% |
778,180
+8,206
| +1% | +$383K |
|
173
Ametek
AME
$55.5B
| $33.7M | 0.11% |
371,136
+223,777
| +152% | +$19.2M |
|
174
Las Vegas Sands
LVS
$30.5B
| $33.7M | 0.11% |
569,781
+569,056
| +78,490% | +$35.3M |
|
175
Sarepta Therapeutics
SRPT
$1.66B
| $33.2M | 0.11% |
218,644
+218,587
| +383,486% | +$26.6M |
|
Similar funds
Bessemer Group's Q2 2019 Portfolio in Review
As of Q2 2019, Bessemer Group held 1,952 positions worth $29.7B, up 14% from $26B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Bessemer Group deployed $2.12B of net new capital in Q2 2019, opening 182 new positions and adding to 563 existing holdings. Its largest new stake was Elanco Animal Health: 3,687,221 shares worth $125M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was UnitedHealth, an estimated $125M trimmed.
- Bessemer Group's largest Q2 2019 buy was Elanco Animal Health: 3,687,221 shares worth $125M.
- Bessemer Group added most to Alibaba in Q2 2019, an estimated $294M increase.
- Bessemer Group's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $125M.
- Bessemer Group fully exited iShares Core MSCI Europe ETF in Q2 2019, selling an estimated $36.4M.
- Bessemer Group's ten largest holdings make up 20% of its $29.7B portfolio in Q2 2019.
- Bessemer Group opened 182 new positions and closed 315 in Q2 2019.
- Bessemer Group's portfolio value rose 14% quarter-over-quarter to $29.7B.
Based on Bessemer Group's 13F filing for Q2 2019, filed 19 Jul 2019.